10-Q Filing

INSIGHT MOLECULAR DIAGNOSTICS INC. CIK: 1642380 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001493152-20-021125`
Period End Date	20200930
Filing Date	20201112
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	ocx-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 72 Cash Flow Statement 96 Comprehensive Income 12

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, no par value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred stock, no par value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.29M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.07M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$366.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Marketable equity securities	`EquitySecuritiesFvNi`	$379.00K	USD	Point-in-time
Marketable equity securities	`EquitySecuritiesFvNi`	$361.00K	USD	Point-in-time
Common stock, no par value	`CommonStockNoParValue`	-	USD	Point-in-time
Common stock, no par value	`CommonStockNoParValue`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$953.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$505.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$22.96M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	57.03M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$11.97M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	67.25M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	57.03M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	67.25M	shares	Point-in-time
Right-of-use assets, machinery and equipment, net, and construction in progress	`RightofuseAssetsMachineryAndEquipmentNet`	$5.66M	USD	Point-in-time
Right-of-use assets, machinery and equipment, net, and construction in progress	`RightofuseAssetsMachineryAndEquipmentNet`	$3.73M	USD	Point-in-time
Equity method investment in Razor	`EquityMethodInvestments`	$13.85M	USD	Point-in-time
Equity method investment in Razor	`EquityMethodInvestments`	$10.96M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$9.19M	USD	Point-in-time
Goodwill	`Goodwill`	$9.19M	USD	Point-in-time
Intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	-	USD	Point-in-time
Intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$15.03M	USD	Point-in-time
Deposits and other noncurrent assets	`DepositsAndOtherNoncurrentAssets`	$2.08M	USD	Point-in-time
Deposits and other noncurrent assets	`DepositsAndOtherNoncurrentAssets`	$2.21M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$57.78M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$39.86M	USD	Point-in-time
Amount due to Lineage and affiliates	`DueToRelatedPartiesCurrent`	$6.00K	USD	Point-in-time
Amount due to Lineage and affiliates	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$469.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$2.61M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$5.12M	USD	Point-in-time
Loans payable, current	`LoansPayableCurrent`	$2.06M	USD	Point-in-time
Loans payable, current	`LoansPayableCurrent`	$1.12M	USD	Point-in-time
Right-of-use and financing lease liabilities, current	`RightofuseAndFinancingLeaseLiabilitiesCurrent`	$230.00K	USD	Point-in-time
Right-of-use and financing lease liabilities, current	`RightofuseAndFinancingLeaseLiabilitiesCurrent`	$456.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.90M	USD	Point-in-time
Loans payable, net of deferred financing costs, noncurrent	`LongTermLoansPayable`	$1.91M	USD	Point-in-time
Loans payable, net of deferred financing costs, noncurrent	`LongTermLoansPayable`	$2.06M	USD	Point-in-time
Financing lease and right of use liabilities, noncurrent	`RightofuseAndFinancingLeaseLiabilitiesNoncurrent`	$2.68M	USD	Point-in-time
Financing lease and right of use liabilities, noncurrent	`RightofuseAndFinancingLeaseLiabilitiesNoncurrent`	$3.87M	USD	Point-in-time
Contingent consideration liabilities	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	-	USD	Point-in-time
Contingent consideration liabilities	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$8.15M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$158.00K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$23.14M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$9.02M	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value, 150,000 shares authorized; 67,251 and 57,032 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$152.01M	USD	Point-in-time
Common stock, no par value, 150,000 shares authorized; 67,251 and 57,032 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$124.58M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-93.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-117.37M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.42M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$30.84M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$29.34M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$34.64M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$39.59M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$33.51M	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$39.86M	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$57.78M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$555.00K	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$713.00K	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	-	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$601.00K	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$1.14M	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.48M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.62M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.62M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.00M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$13.38M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.00M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$9.09M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.00M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$1.57M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$4.62M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$1.15M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$630.00K	USD	1 Quarter
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	-	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-2.98M	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-2.98M	USD	1 Quarter
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	-	USD	1 Quarter
Total costs and operating expenses	`OperatingExpenses`	$5.26M	USD	1 Quarter
Total costs and operating expenses	`OperatingExpenses`	$24.16M	USD	3 Qtrs
Total costs and operating expenses	`OperatingExpenses`	$6.80M	USD	1 Quarter
Total costs and operating expenses	`OperatingExpenses`	$14.72M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.26M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-23.44M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-6.24M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-14.72M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$282.00K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$135.00K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-78.00K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-175.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-103.00K	USD	1 Quarter
Unrealized gain (loss) on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-18.00K	USD	3 Qtrs
Unrealized gain (loss) on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$20.00K	USD	1 Quarter
Unrealized gain (loss) on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-13.00K	USD	3 Qtrs
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	-	USD	1 Quarter
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	$-1.11M	USD	3 Qtrs
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	$-482.00K	USD	1 Quarter
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	-	USD	3 Qtrs
Other income (expenses), net	`OtherNonoperatingIncomeExpense`	$31.00K	USD	3 Qtrs
Other income (expenses), net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income (expenses), net	`OtherNonoperatingIncomeExpense`	$1.00K	USD	1 Quarter
Other income (expenses), net	`OtherNonoperatingIncomeExpense`	$-25.00K	USD	3 Qtrs
Total other income (expenses), net	`NonoperatingIncomeExpense`	$-1.27M	USD	3 Qtrs
Total other income (expenses), net	`NonoperatingIncomeExpense`	$32.00K	USD	1 Quarter
Total other income (expenses), net	`NonoperatingIncomeExpense`	$-539.00K	USD	1 Quarter
Total other income (expenses), net	`NonoperatingIncomeExpense`	$244.00K	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.22M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-14.47M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.72M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.78M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-1.09M	USD	3 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-5.22M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-6.78M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-23.62M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-14.47M	USD	3 Qtrs
Net loss per share: basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Net loss per share: basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.36	USD	3 Qtrs
Net loss per share: basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	3 Qtrs
Net loss per share: basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Weighted average shares outstanding: basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	51,973.00	shares	1 Quarter
Weighted average shares outstanding: basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	50,217.00	shares	3 Qtrs
Weighted average shares outstanding: basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	64,843.00	shares	3 Qtrs
Weighted average shares outstanding: basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	67,247.00	shares	1 Quarter

Cash Flow Statement 96 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.78M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-23.62M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-14.47M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$69.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$529.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$278.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$84.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$59.00K	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	-	USD	3 Qtrs
Amortization of right-of-use assets and liabilities	`AmortizationOfRightOfUseAssetsAndLiabilities`	-	USD	3 Qtrs
Amortization of right-of-use assets and liabilities	`AmortizationOfRightOfUseAssetsAndLiabilities`	$959.00K	USD	3 Qtrs
Impairment charge for long-lived assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	3 Qtrs
Impairment charge for long-lived assets	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$88.00K	USD	3 Qtrs
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	-	USD	1 Quarter
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	$-1.11M	USD	3 Qtrs
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	$-482.00K	USD	1 Quarter
Pro rata loss from equity method investment in Razor	`IncomeLossFromEquityMethodInvestments`	-	USD	3 Qtrs
Amortization of prepaid maintenance	`AmortizationOfPrepaidMaintenance`	$52.00K	USD	3 Qtrs
Amortization of prepaid maintenance	`AmortizationOfPrepaidMaintenance`	$28.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$4.08M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.78M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.21M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$821.00K	USD	1 Quarter
Unrealized loss on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-103.00K	USD	1 Quarter
Unrealized loss on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-18.00K	USD	3 Qtrs
Unrealized loss on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$20.00K	USD	1 Quarter
Unrealized loss on marketable equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-13.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$30.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$80.00K	USD	3 Qtrs
Warrants issued for advisory services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Warrants issued for advisory services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$234.00K	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	-	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-2.98M	USD	3 Qtrs
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$-2.98M	USD	1 Quarter
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	-	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-1.09M	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$25.00K	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$372.00K	USD	3 Qtrs
Amount due to Lineage and affiliates	`IncreaseDecreaseInDueToRelatedParties`	$-2.10M	USD	3 Qtrs
Amount due to Lineage and affiliates	`IncreaseDecreaseInDueToRelatedParties`	$-6.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$238.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$575.00K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-416.00K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.84M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.41M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-19.83M	USD	3 Qtrs
Acquisition of Insight Genetics, net of cash acquired	`PaymentsToAcquireEquityMethodInvestments`	-	USD	3 Qtrs
Acquisition of Insight Genetics, net of cash acquired	`PaymentsToAcquireEquityMethodInvestments`	$6.19M	USD	3 Qtrs
Equity method investment in Razor	`PaymentsForEquityMethodInvestment`	$11.24M	USD	3 Qtrs
Equity method investment in Razor	`PaymentsForEquityMethodInvestment`	$4.00M	USD	3 Qtrs
Purchases of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.06M	USD	3 Qtrs
Purchases of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.00K	USD	3 Qtrs
Security deposit and other	`ProceedsFromSecurityDepositAndOther`	$-6.00K	USD	3 Qtrs
Security deposit and other	`ProceedsFromSecurityDepositAndOther`	$64.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.26M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.20M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$72.00K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$943.00K	USD	3 Qtrs
Proceeds from sale of common shares	`ProceedsFromIssuanceOfCommonStock`	$18.34M	USD	3 Qtrs
Proceeds from sale of common shares	`ProceedsFromIssuanceOfCommonStock`	$40.25M	USD	3 Qtrs
Financing costs to issue common shares	`PaymentsOfStockIssuanceCosts`	$3.25M	USD	3 Qtrs
Financing costs to issue common shares	`PaymentsOfStockIssuanceCosts`	$58.00K	USD	3 Qtrs
Common shares received and retired for employee taxes paid	`CommonSharesReceivedAndRetiredForEmployeeTaxesPaid`	$14.00K	USD	3 Qtrs
Common shares received and retired for employee taxes paid	`CommonSharesReceivedAndRetiredForEmployeeTaxesPaid`	-	USD	3 Qtrs
Repayment of loan payable	`RepaymentsOfDebt`	$600.00K	USD	3 Qtrs
Repayment of loan payable	`RepaymentsOfDebt`	$125.00K	USD	3 Qtrs
Repayment of financing lease obligations	`FinanceLeasePrincipalPayments`	$323.00K	USD	3 Qtrs
Repayment of financing lease obligations	`FinanceLeasePrincipalPayments`	$53.00K	USD	3 Qtrs
Proceeds from PPP loan	`ProceedsFromLoans`	$1.14M	USD	3 Qtrs
Proceeds from PPP loan	`ProceedsFromLoans`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$37.02M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.31M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.41M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.78M	USD	3 Qtrs
At beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.77M	USD	Point-in-time
At beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.03M	USD	Point-in-time
At beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.99M	USD	Point-in-time
At beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.44M	USD	Point-in-time
At end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$23.77M	USD	Point-in-time
At end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.03M	USD	Point-in-time
At end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.99M	USD	Point-in-time
At end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$19.44M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$76.00K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$131.00K	USD	3 Qtrs
Common stock issued for acquisition of Insight Genetics	`CommonStockIssuedForAcquisition`	-	USD	3 Qtrs
Common stock issued for acquisition of Insight Genetics	`CommonStockIssuedForAcquisition`	$5.00M	USD	3 Qtrs
Initial fair value of contingent consideration at acquisition date	`InitialFairValueOfContingentConsiderationAtAcquisitionDate`	-	USD	3 Qtrs
Initial fair value of contingent consideration at acquisition date	`InitialFairValueOfContingentConsiderationAtAcquisitionDate`	$11.13M	USD	3 Qtrs
Holdback liability	`HoldbackLiability`	-	USD	3 Qtrs
Holdback liability	`HoldbackLiability`	$600.00K	USD	3 Qtrs
Construction in progress, machinery and equipment purchases included in accounts payable, accrued liabilities and landlord liability	`ConstructionInProgressMachineryAndEquipmentPurchasesIncludedInAccountsPayableAccruedLiabilitiesAndLandlordLiability`	$353.00K	USD	3 Qtrs
Construction in progress, machinery and equipment purchases included in accounts payable, accrued liabilities and landlord liability	`ConstructionInProgressMachineryAndEquipmentPurchasesIncludedInAccountsPayableAccruedLiabilitiesAndLandlordLiability`	$1.11M	USD	3 Qtrs

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
NET LOSS	`NetIncomeLoss`	$-5.22M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-6.78M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-23.62M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-14.47M	USD	3 Qtrs
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	3 Qtrs
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	3 Qtrs
Other comprehensive loss, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	-	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-6.78M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-23.62M	USD	3 Qtrs
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-5.22M	USD	1 Quarter
COMPREHENSIVE LOSS	`ComprehensiveIncomeNetOfTax`	$-14.47M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.